
This article is published in association with European Investment Bank. Danish biotech SNIPR Biome will get up to €20 million venture debt from the European Investment Bank (EIB) to step up Europe’s fight against antimicrobial resistance to medicines. The company will use the EIB credit to develop new medicines for infections where existing antibiotics are no […]


















